What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
His primary scientific interests are in Immunology, Cancer research, Immune system, Immunotherapy and Pathology.
His studies in Cytokine, Tumor necrosis factor alpha, CD8, Interferon gamma and Spleen are all subfields of Immunology research.
His Cancer research study integrates concerns from other disciplines, such as Apoptosis, Interleukin 21, Gene, Antibody and Bone marrow.
His research in Interleukin 21 intersects with topics in Interleukin 12 and Interleukin 18.
His Immune system research includes elements of Cell type, Cytolysis and Cell biology.
The study incorporates disciplines such as Oxidative stress, Hepatitis B and In vitro in addition to Pathology.
His most cited work include:
- Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis (449 citations)
- Loss of T-Cell Receptor ζ Chain and p56lck in T-Cells Infiltrating Human Renal Cell Carcinoma (367 citations)
- Role of NK cells in the control of metastatic spread and growth of tumor cells in mice (320 citations)
What are the main themes of his work throughout his whole career to date?
Robert H. Wiltrout spends much of his time researching Immunology, Cancer research, Immune system, Molecular biology and In vivo.
His Interleukin 12 research extends to Immunology, which is thematically connected.
He usually deals with Interleukin 12 and limits it to topics linked to Interleukin 21 and IL-2 receptor.
Robert H. Wiltrout interconnects Carcinogenesis, Cancer, Metastasis, Pathology and Cytotoxic T cell in the investigation of issues within Cancer research.
His research on Molecular biology also deals with topics like
- Natural killer cell, which have a strong connection to Cellular immunity,
- Cytolysis which intersects with area such as Cell biology.
His In vivo research incorporates elements of In vitro and Monoclonal antibody.
He most often published in these fields:
- Immunology (43.80%)
- Cancer research (31.40%)
- Immune system (18.60%)
What were the highlights of his more recent work (between 2009-2018)?
- Immunology (43.80%)
- Cancer research (31.40%)
- Immunotherapy (16.12%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Cancer research, Immunotherapy, Immune system and Cancer.
His research integrates issues of Interleukin 12 and Myeloid-derived Suppressor Cell in his study of Immunology.
His Interleukin 12 research includes elements of Spleen and Bone marrow.
The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Nitric oxide synthase, Oncogene and Lung.
His Immunotherapy research incorporates themes from Tumor necrosis factor alpha, PI3K/AKT/mTOR pathway, Nitric oxide and Cytokine.
His work in the fields of Immune system, such as CXCR3, Chemokine receptor and Chemokine, overlaps with other areas such as Mammary tumor.
Between 2009 and 2018, his most popular works were:
- Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood (139 citations)
- Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma (130 citations)
- Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections (93 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
His primary areas of investigation include Immunology, Immunotherapy, Immune system, Tumor microenvironment and Cancer research.
The study incorporates disciplines such as Metastasis and Cytokine in addition to Immunotherapy.
His Immune system study combines topics from a wide range of disciplines, such as Gene knockdown and Antigen.
His work carried out in the field of Tumor microenvironment brings together such families of science as Tissue inhibitor of metalloproteinase, Apoptosis, CD8 and Myeloid-derived Suppressor Cell.
Robert H. Wiltrout has included themes like Nitric oxide synthase, Nitric oxide, Primary tumor and Etiology in his Cancer research study.
His IL-2 receptor research is multidisciplinary, relying on both Natural killer T cell, Molecular biology and Interferon gamma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
